Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms

First Affiliated Hospital of Zhejiang University80 enrolled

Overview

The purpose of this study is to evaluate the safety and efficacy of endoscopic ultrasonography (EUS) guided laser ablation liver, pancreas, and retroperitoneal tumors, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Refractory Neoplasms

Interventions

EUS-guided laser ablation for refractory neoplasmsPROCEDURE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with refractory neoplasms including small hepatocellular carcinoma adjacent to the gastrointestinal tract, pancreatic neuroendocrine tumor, retroperitoneal tumor with less than 3 cm in diameter; * Patients with Child-Pugh A/B; * Patients with PLT ≥ 50\*10E9/L and PT ≤ 20s. Exclusion Criteria: * Patients with severe cardiopulmonary disease, intolerant endoscopy and anesthesia, upper gastrointestinal bleeding in shock, corrosive esophagitis and acute gastritis.

Locations (1)

The First Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, China

RECRUITING

Outcomes

Primary Outcomes

80 patients of refractory neoplasms with EUS-guided laser ablation-related effectivity as assessed by MRI

Time frame: up to 24 months

Central Contacts

Tian'an Jiang, Phd

CONTACT

+86 18857127666 tiananjiang@126.com

Guo Tian, Master

CONTACT

+86 13600529967 871035504@qq.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.